Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Moderna and Lonza announced a 10-year strategic collaboration agreement to enable larger scale manufacture of Moderna’s mRNA vaccine against the novel coronavirus.
read more
Moffitt Cancer Center announced today the launch of a first-of-its-kind contract research organization (CRO) focused on accelerating immunotherapy research. The subsidiary will provide a one-stop-shop for pharmaceutical and biotech companies to ...
read more
Thursday, December 22, 2016
Moffitt Cancer Center has chosen Cryoport, Inc. to provide support for its immunology program, cancer research, and therapy programs and lab moves.
read more
Thursday, January 14, 2021
Mogrify and the MRC Laboratory of Molecular Biology (LMB) have announced an exploratory research collaboration.
read more
Tuesday, October 13, 2020
Mogrify announced the introduction of EpiMOGRIFY. The platform models the epigenetic state of the cell to predict the switches important for cell identity, cell maintenance, directed differentiation and cell conversion.
read more
Molecular Profiles Ltd., a subsidiary of Columbia Laboratories, Inc., (Nasdaq: CBRX), is set to increase awareness and uptake of its pharmaceutical development services in the North American market following the appointment of a new head of US sales.
read more
MolecularMatch announced the USPTO has issued a patent covering its Precision Medicine Service for use by hospitals, pharmaceutical companies, laboratories, and health information systems.
read more
Thursday, February 21, 2019
MolecularMD, a molecular diagnostic specialty laboratory that enables the development and commercialization of precision medicines in oncology, has been acquired by ICON.
read more
Molecule Holdings (MH) has secured North American distribution for one of the first COVID-19 IgM/IgG Antibody Rapid Tests to receive FDA/EUA approval.
read more
Friday, September 18, 2020
Moleculin Biotech has contracted with an independent laboratory to test the antiviral activity of its WP1122 portfolio in a COVID-19 animal model.
read more
Wednesday, April 10, 2019
Moleculin Biotech announced it has successfully expanded the clinical supply of Annamycin for its on-going clinical trials via BSP Pharmaceuticals S.p.A. in Latina, Italy.
read more
Friday, February 05, 2021
Moleculin Biotech has signed an agreement with Catalyst to manage its US clinical trial to study the ability of Annamycin to treat soft tissue sarcoma that has metastasized to the lungs.
read more
Harbour BioMed has entered into an exclusive strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical to develop and commercialize A167.
read more
Mologic and BioSure are working together to produce a COVID-19 antibody self-test.
read more
Monash University and ClinChoice announced a strategic partnership designed to fast-track early-phase clinical trials and bring groundbreaking health innovations and discoveries closer to patients worldwide.
read more